Third, the untargeted HSA adductomics assay provides an unbiased and unique vantage point with which to evaluate ROS disposition during the month preceding phlebotomy and to determine whether ROS may have contributed to lung cancer. This evidence concerns the gene ALB and lung carcinoma.